Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19
- PMID: 35218366
- PMCID: PMC8881896
- DOI: 10.1007/s00134-022-06642-z
Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19
Erratum in
-
Correction to: Increased 30-day mortality in very old ICU patients with COVID-19 compared to patients with respiratory failure without COVID-19.Intensive Care Med. 2022 Jun;48(6):797-799. doi: 10.1007/s00134-022-06674-5. Intensive Care Med. 2022. PMID: 35357546 Free PMC article. No abstract available.
Abstract
Purpose: The number of patients ≥ 80 years admitted into critical care is increasing. Coronavirus disease 2019 (COVID-19) added another challenge for clinical decisions for both admission and limitation of life-sustaining treatments (LLST). We aimed to compare the characteristics and mortality of very old critically ill patients with or without COVID-19 with a focus on LLST.
Methods: Patients 80 years or older with acute respiratory failure were recruited from the VIP2 and COVIP studies. Baseline patient characteristics, interventions in intensive care unit (ICU) and outcomes (30-day survival) were recorded. COVID patients were matched to non-COVID patients based on the following factors: age (± 2 years), Sequential Organ Failure Assessment (SOFA) score (± 2 points), clinical frailty scale (± 1 point), gender and region on a 1:2 ratio. Specific ICU procedures and LLST were compared between the cohorts by means of cumulative incidence curves taking into account the competing risk of discharge and death.
Results: 693 COVID patients were compared to 1393 non-COVID patients. COVID patients were younger, less frail, less severely ill with lower SOFA score, but were treated more often with invasive mechanical ventilation (MV) and had a lower 30-day survival. 404 COVID patients could be matched to 666 non-COVID patients. For COVID patients, withholding and withdrawing of LST were more frequent than for non-COVID and the 30-day survival was almost half compared to non-COVID patients.
Conclusion: Very old COVID patients have a different trajectory than non-COVID patients. Whether this finding is due to a decision policy with more active treatment limitation or to an inherent higher risk of death due to COVID-19 is unclear.
Trial registration: ClinicalTrials.gov NCT03370692 NCT04321265.
Keywords: COVID; Intensive care; Mortality; Old patients; Treatment limitation.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Comment in
-
ICU organization and disparities in clinical trajectories and outcomes during the pandemic.Intensive Care Med. 2022 Aug;48(8):1120-1121. doi: 10.1007/s00134-022-06728-8. Epub 2022 May 9. Intensive Care Med. 2022. PMID: 35534643 Free PMC article. No abstract available.
-
Covid-19-ARDS hat bei über 80-Jährigen eine höhere Sterblichkeit als non-Covid-ARDS.Laryngorhinootologie. 2023 Apr;102(4):253. doi: 10.1055/a-1984-2813. Epub 2023 Apr 11. Laryngorhinootologie. 2023. PMID: 37040744 German. No abstract available.
References
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical